Home / Stocks / TERN

TERN insider trading

Terns Pharmaceuticals, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
7
Bought · 24 mo
$5.3M
Buys · last 90 days
0 · $0
Most recent buy
2025-06-30

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-01-16Burroughs Amy L.
Chief Executive Officer
Sold61,228$37.02$2.3M
2026-01-06Burroughs Amy L.
Chief Executive Officer
Sold71,339$38.10$2.7M
2025-06-30Gengos Andrew
Chief Financial Officer
Bought10,000$3.93$39k
2025-06-25Burroughs Amy L.
Chief Executive Officer
Bought23,314$3.87$90k
2025-06-16Gengos Andrew
Chief Financial Officer
Bought15,000$3.81$57k
2025-02-03Jung Melita Sun
Chief Business Officer
Bought2,250$5.11$11k
2025-02-03Burroughs Amy L.
Chief Executive Officer
Bought510$5.11$3k
2024-12-09Burroughs Amy L.
Chief Executive Officer
Bought15,450$7.15$110k
2024-09-17Lu Hongbo
Director
Bought476,190$10.50$5.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Lu HongboDirector1$5.0M
Burroughs Amy L.Chief Executive Officer3$203k
Gengos AndrewChief Financial Officer2$96k
Jung Melita SunChief Business Officer1$11k

See TERN on the chart

Every insider buy and sell for TERN plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.